Werewolf Therapeutics, Inc. (HOWL)
USD 1.48
(-9.76%)
USD 1.48
(-9.76%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 19.94 Million | 16.4 Million | - | - | - |
| Cost of Revenue | 38.9 Million | 2.51 Million | 735 Thousand | 777 Thousand | 463 Thousand |
| Gross Profit | -18.96 Million | 13.89 Million | -735 Thousand | -777 Thousand | -463 Thousand |
| Operating Expenses | 60.44 Million | 72.45 Million | 50.08 Million | 22.4 Million | 9.93 Million |
| Selling, General and Administrative Expenses | 18.67 Million | 18.69 Million | 14.81 Million | 5.76 Million | 3.59 Million |
| Research and Development Expenses | 41.77 Million | 53.76 Million | 35.26 Million | 16.64 Million | 6.34 Million |
| Other Expenses | - | 2.24 Million | 104 Thousand | 7.26 Million | 430 Thousand |
| Cost and Expenses | 60.44 Million | 72.45 Million | 50.08 Million | 22.4 Million | 9.93 Million |
| Operating Income | -40.5 Million | -56.05 Million | -50.08 Million | -22.4 Million | -9.93 Million |
| Interest Expense | 3.13 Million | - | - | - | 372 Thousand |
| Income Tax Expense | - | -2.24 Million | -216 Thousand | -101 Thousand | 742 Thousand |
| Earnings before Tax | -37.36 Million | -53.81 Million | -49.98 Million | -15.04 Million | -10.24 Million |
| Net Income | -37.36 Million | -51.56 Million | -49.76 Million | -14.93 Million | -10.99 Million |
| Earnings Per Share Basic | -1.05 | -1.79 | -1.82 | -0.52 | -0.38 |
| Earnings Per Share Diluted | -1.05 | -1.79 | -1.82 | -0.52 | -0.38 |
| Weighted Average Shares Outstanding | 35.64 Million | 28.86 Million | 27.31 Million | 28.66 Million | 28.66 Million |
| Weighted Average Shares Outstanding (Diluted) | 35.64 Million | 28.86 Million | 27.31 Million | 28.66 Million | 28.66 Million |
| Gross Margin | -0.95 | 0.85 | - | - | - |
| EBIT Margin | -1.63 | -3.42 | - | - | - |
| Profit Margin | -1.87 | -3.14 | - | - | - |
| EBITDA | -32.46 Million | -51.3 Million | -49.24 Million | -14.26 Million | -9.41 Million |
| Earnings Before Tax Margin | -2.03 | -3.42 | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.14 Million | 742 Thousand | 1.5 Million | 19.94 Million | 5.89 Million | 8.08 Million |
| Cost of Revenue | 454 Thousand | 464 Thousand | 460 Thousand | 1.76 Million | 445 Thousand | 773 Thousand |
| Gross Profit | 689 Thousand | 278 Thousand | 1.04 Million | 18.17 Million | 5.45 Million | 7.3 Million |
| Operating Expenses | 19.64 Million | 17.44 Million | 14 Million | 58.68 Million | 15.14 Million | 14.14 Million |
| Selling, General and Administrative Expenses | 4.37 Million | 4.53 Million | 4.35 Million | - | 4.31 Million | 4.56 Million |
| Research and Development Expenses | 15.27 Million | 12.9 Million | 9.64 Million | - | 10.83 Million | 9.58 Million |
| Other Expenses | 1.61 Million | -1000.00 | -6000.00 | -1.14 Million | 966 Thousand | -25 Thousand |
| Cost and Expenses | 20.1 Million | 17.9 Million | 14.46 Million | 60.44 Million | 15.14 Million | 14.14 Million |
| Operating Income | -18.96 Million | -17.16 Million | -12.96 Million | -40.5 Million | -9.25 Million | -6.06 Million |
| Interest Expense | 1.14 Million | 1 Million | 1.23 Million | 3.13 Million | 900 Thousand | 955 Thousand |
| Income Tax Expense | - | -1.00 | 2.1 Million | 1.59 Million | -445 Thousand | -994 Thousand |
| Earnings before Tax | -17.24 Million | -16.19 Million | -12 Million | -37.36 Million | -8.28 Million | -5.09 Million |
| Net Income | -17.24 Million | -16.19 Million | -12 Million | -37.36 Million | -8.28 Million | -5.09 Million |
| Earnings Per Share Basic | -0.40 | -0.39 | -0.33 | - | -0.23 | -0.14 |
| Earnings Per Share Diluted | -0.40 | -0.39 | -0.33 | - | -0.23 | -0.14 |
| Weighted Average Shares Outstanding | 43.52 Million | 41.6 Million | 36.57 Million | 35.64 Million | 35.65 Million | 35.55 Million |
| Weighted Average Shares Outstanding (Diluted) | 43.52 Million | 41.6 Million | 36.57 Million | 35.64 Million | 35.65 Million | 35.55 Million |
| Gross Margin | 0.60 | 0.37 | 0.69 | 0.91 | 0.92 | 0.90 |
| EBIT Margin | -16.19 | -22.50 | -8.33 | - | -1.57 | -0.70 |
| Profit Margin | -15.09 | -21.82 | -8.00 | -1.87 | -1.40 | -0.63 |
| EBITDA | -18.5 Million | -16.69 Million | -12.5 Million | - | -9.25 Million | -5.63 Million |
| Earnings Before Tax Margin | -16.59 | -23.13 | -8.64 | -2.03 | -1.57 | -0.75 |
NVVEW
THO
0255
BESI
A3D
ADZ